WHO’s Working for Health 2022–2030 Action Plan

By Staff Writer

February 6, 2023

Introduction:

Achieving universal health care (UHC) is a World Health Organisation (WHO) strategic priority, with the goal of 1 billion more people benefitting from universal health coverage by 2025. This publication on health and care workforce planning provides a rationale for the related actions of the Working for Health progression model.

The Need for Planning and Financing:

Planning and financing are integral to the efficient and cost-effective development of health and care workforce policies. Their importance is particularly evident in low- and middle-income countries (LMICs), where technical and institutional capacity to support planning and financing is often inadequate. In such strained economic environments, building this capacity is a priority.

The Working for Health Model:

The Working for Health progression model offers a pathway for countries facing critical workforce challenges to progressively optimise, build, and strengthen their workforce. The model focuses on three key themes: planning and financing, education and employment, and protection and performance.

The Current Context:

The COVID-19 pandemic has highlighted the need for effective planning and strategic financing in the health and care workforce. LMICs face challenges such as building labour market demand for health and care workers, mobilising sufficient and sustainable revenue, and attracting and retaining workers within the health system.

Policy Landscape:

The WHO Global Strategy presents a range of policy options to advance the health and care workforce agenda. These options emphasise the need to strengthen the integration and synergy of health workforce policy with broader development strategies.

Challenges:

The COVID-19 pandemic has had a devastating impact on economies worldwide. Financial resources allocated to health and care workforce are constrained by the economic crises facing many countries. In addition, many countries lack the technical and institutional capacity to translate evidence-based information into policy development and implementation.

Future Directions:

The challenges faced by the health and care workforce require strategic planning and financing. Investment in the health and care workforce is critical in emergency and disaster risk management, building the resilience of the health system to shocks and surges in demand.

Conclusion:

The health and care workforce is a vital component of the healthcare ecosystem. As such, it is essential to invest in strategic planning and financing to ensure its growth and sustainability. By doing so, we can ensure a resilient health system capable of meeting the needs of populations worldwide.

 

 

Reference url

Recent Posts

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.